The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial of the 1st line combination therapy of eribulin and trastuzumab for advanced or recurrent HER2-positive breast cancer.
 
Koichi Sakaguchi
No Relationships to Disclose
 
Katsuhiko Nakatsukasa
No Relationships to Disclose
 
Tetsuya Taguchi
No Relationships to Disclose